I am so glad you reminded us of this press release. I posted recently about this exact item the other day. All the focus has been on skin care/Varm Cosmo etc. With the confirmation of GMP is imminent the second key product formulation could be the money maker for mgc. MGCON00CA1 for oncology treatment, the reference to cancer treatment is huge. This could be huge. I know Bret has (probably) been overwhelmed with emails about Korea but this is what I would love some answers on. Where we at?
cannepil question and other questions, page-22
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.76M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8971 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 1 | 1 |
View Market Depth
| Last trade - 09.00am 02/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable